These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10066096)
41. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645 [TBL] [Abstract][Full Text] [Related]
42. Hypermethylation of the RASSF1A gene in gliomas. Gao Y; Guan M; Su B; Liu W; Xu M; Lu Y Clin Chim Acta; 2004 Nov; 349(1-2):173-9. PubMed ID: 15469871 [TBL] [Abstract][Full Text] [Related]
43. EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index. Purkait S; Sharma V; Jha P; Sharma MC; Suri V; Suri A; Sharma BS; Sarkar C Neuropathology; 2015 Oct; 35(5):421-31. PubMed ID: 26096306 [TBL] [Abstract][Full Text] [Related]
44. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787 [TBL] [Abstract][Full Text] [Related]
45. Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Enomoto T; Fujita M; Cheng C; Nakashima R; Ozaki M; Inoue M; Nomura T Br J Cancer; 1995 Mar; 71(3):462-7. PubMed ID: 7880725 [TBL] [Abstract][Full Text] [Related]
46. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas. Fults D; Pedone C Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623 [TBL] [Abstract][Full Text] [Related]
47. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893 [TBL] [Abstract][Full Text] [Related]
48. The DCC protein and prognosis in colorectal cancer. Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264 [TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue. Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749 [TBL] [Abstract][Full Text] [Related]
50. Studies of the deleted in colorectal cancer gene in normal and neoplastic tissues. Fearon ER; Ekstrand BC; Hu G; Pierceall WE; Reale MA; Bigner SH Cold Spring Harb Symp Quant Biol; 1994; 59():637-43. PubMed ID: 7587124 [TBL] [Abstract][Full Text] [Related]
51. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival. Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754 [TBL] [Abstract][Full Text] [Related]
52. Loss of DCC expression in astrocytomas: relation to p53 abnormalities, cell kinetics, and survival. Hara A; Saegusa M; Mikami T; Okayasu I J Clin Pathol; 2001 Nov; 54(11):860-5. PubMed ID: 11684721 [TBL] [Abstract][Full Text] [Related]
54. Early loss of deleted in colorectal carcinoma gene transcript detected in a group of benign colon adenomas. Traicoff Ju; Willson J; Markowitz SD J Biomed Sci; 2002; 9(6 Pt 2):716-20. PubMed ID: 12432238 [TBL] [Abstract][Full Text] [Related]
55. Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphoma. Younes A; Zhao S; Jendiroba D; Kleine HD; Cabanillas F; Andreeff M Blood; 1995 May; 85(10):2813-6. PubMed ID: 7742542 [TBL] [Abstract][Full Text] [Related]
56. [Prognosis value of p53 gene and cellular proliferation factors in malignant supratentorial gliomas]. Gil-Salú JL; González-Darder JM; Barcia Albacar JA; Pesudo JV; Vera-Román JM; Lázaro R; Alós M Neurocirugia (Astur); 2001; 12(2):125-32. PubMed ID: 11706441 [TBL] [Abstract][Full Text] [Related]
57. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma. Sun XF; Rütten S; Zhang H; Nordenskjöld B J Clin Oncol; 1999 Jun; 17(6):1745-50. PubMed ID: 10561211 [TBL] [Abstract][Full Text] [Related]
58. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947 [TBL] [Abstract][Full Text] [Related]
59. Loss of DCC gene expression during ovarian tumorigenesis: relation to tumour differentiation and progression. Saegusa M; Machida D; Okayasu I Br J Cancer; 2000 Feb; 82(3):571-8. PubMed ID: 10682668 [TBL] [Abstract][Full Text] [Related]
60. Deregulated expression of cry1 and cry2 in human gliomas. Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]